logo mainlogo darklogo main
  • HOME
  • ABOUT
    • Our Story
    • Quality
    • Clients
  • PRODUCTS
    • APIs
      • APIs List
      • Amisulpride
      • Bilastine
      • Bedaquiline
      • Ethopabate
      • Vonoprazan
      • Rivaroxaban
      • Metoclopramide
      • Carvedilol
      • Silodosin
      • Dapagliflozin
      • Empagliflozin
      • Oseltamivir Phosphate
      • Carglumic Acid
      • Tofacitinib Citrate
      • Posaconazole
      • Nirmatrelvir
      • Bumetanide
      • Brivaracetam
      • Resmetirom
    • Drug Intermediates
    • Biological
    • Reaction Capabilities
  • CSR
  • CONTACT
logo mainlogo darklogo main
  • HOME
  • ABOUT
    • Our Story
    • Quality
    • Clients
  • PRODUCTS
    • APIs
      • APIs List
      • Amisulpride
      • Bilastine
      • Bedaquiline
      • Ethopabate
      • Vonoprazan
      • Rivaroxaban
      • Metoclopramide
      • Carvedilol
      • Silodosin
      • Dapagliflozin
      • Empagliflozin
      • Oseltamivir Phosphate
      • Carglumic Acid
      • Tofacitinib Citrate
      • Posaconazole
      • Nirmatrelvir
      • Bumetanide
      • Brivaracetam
      • Resmetirom
    • Drug Intermediates
    • Biological
    • Reaction Capabilities
  • CSR
  • CONTACT
logo main logo darklogo light
  • HOME
  • ABOUT
    • Our Story
    • Quality
    • Clients
  • PRODUCTS
    • APIs
      • APIs List
      • Amisulpride
      • Bilastine
      • Bedaquiline
      • Ethopabate
      • Vonoprazan
      • Rivaroxaban
      • Metoclopramide
      • Carvedilol
      • Silodosin
      • Dapagliflozin
      • Empagliflozin
      • Oseltamivir Phosphate
      • Carglumic Acid
      • Tofacitinib Citrate
      • Posaconazole
      • Nirmatrelvir
      • Bumetanide
      • Brivaracetam
      • Resmetirom
    • Drug Intermediates
    • Biological
    • Reaction Capabilities
  • CSR
  • CONTACT
Empagliflozin API Manufacturing: GMP & USFDA Standards
September 11, 2025
Uncategorized

Empagliflozin API Manufacturing Standards: GMP, USFDA, and DCGI Compliance

Empagliflozin API Manufacturing Standards: GMP, USFDA, and DCGI Compliance Empagliflozin is a vital Active Pharmaceutical Ingredient (API) used in SGLT2 inhibitors for Type 2 diabe

Read More
Empagliflozin API: Uses, CAS No & Diabetes Drug Applications
September 11, 2025
Uncategorized

What is Empagliflozin API? Uses, CAS No, and Applications in Diabetes Treatment

Empagliflozin API: Uses, CAS No & Diabetes Drug Applications   Empagliflozin API is a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor, widely used in the treat

Read More
DMF Filing & Regulatory Requirements for Dapagliflozin Export from India
September 11, 2025
Uncategorized

DMF Filing & Regulatory Requirements for Dapagliflozin Export from India

DMF Filing & Regulatory Requirements for Dapagliflozin Export from India Exporting APIs like Dapagliflozin from India involves rigorous regulatory compliance, especially for Dr

Read More
How Dapagliflozin API Is Manufactured: From Chemistry to Compliance
September 11, 2025
Uncategorized

How Dapagliflozin API Is Manufactured: From Chemistry to Compliance

How Dapagliflozin API Is Manufactured: From Chemistry to Compliance   Dapagliflozin is a key active pharmaceutical ingredient (API) used for managing Type 2 diabetes. Its manu

Read More
SGLT2 Inhibitors in India: Approvals & Market Insights
September 9, 2025
Uncategorized

An Overview of SGLT2 Inhibitors in India: Regulatory Approvals and Market Trends

An Overview of SGLT2 Inhibitors in India: Regulatory Approvals and Market Trends   SGLT2 inhibitors represent a breakthrough in diabetes care, with India emerging as a major h

Read More
Dapagliflozin API Pricing Factors: Key Cost Drivers Explained
September 9, 2025
Uncategorized

A Breakdown of Dapagliflozin API Pricing: What Influences the Cost per Kg?

A Breakdown of Dapagliflozin API Pricing: What Influences the Cost per Kg? Dapagliflozin API, a high-demand SGLT2 inhibitor for diabetes and chronic kidney disease, faces growing g

Read More
Dapagliflozin vs Empagliflozin: Key Differences for Formulators & Buyers
September 9, 2025
Uncategorized

Dapagliflozin vs Empagliflozin: Key Differences for Formulators & Buyers

Dapagliflozin vs Empagliflozin: Key Differences for Formulators & Buyers   When choosing between Dapagliflozin and Empagliflozin for type 2 diabetes treatments, formulatio

Read More

Posts pagination

01 02
Bio synth

Biochemical & Synthetic
Products Private Limited

About
  • Our Story
  • Quality
  • Clients
  • CSR
  • Blogs
Products
  • APIs
  • Advanced Drug Intermediates
  • Biological
  • Reaction Capabilities
  • Product Intermediates
APIs List
  • Bedaquiline
  • Bilastine
  • Vonoprazan
  • Amisulpride
  • Metoclopramide
  • Ethopabate
  • Rivaroxaban
  • Carvedilol
  • Silodosin
  • Dapagliflozin
  • Empagliflozin
  • Oseltamivir Phosphate
  • Carglumic Acid
  • Tofacitinib Citrate
  • Nirmatrelvir
  • Posaconazole
  • Bumetanide
  • Brivaracetam
  • Resmetirom
Contact

Plot No. 11/6/2029, Phase 2, S.V.C.I.E, Balanagar, Hyderabad - 500037, Telangana, India

+91 77997 74402 (India)

info@bio-synth.com

© 2024 All Rights Reserved

  • →
  • Contact Us
    Contact Us

  • Phone
  • WhatsApp